GLP-1 receptor agonists like semaglutide appear to weaken the link between impulsive tendencies and violent behavior opening a potential new application in mental health.
Tag: Wegovy
Ozempic and Wegovy Linked to Surprising Drop in Violent Behavior in New Research Analysis
New study suggests GLP-1 receptor agonists may reduce impulsive aggression through effects on brain reward and impulse control systems.
Ozempic and Wegovy Linked to Surprising Drop in Violent Behavior in Rutgers Study
Rutgers researchers found that GLP-1 drugs may weaken the link between impulsive tendencies and violent behaviour, though researchers stress causation not proven.
Ozempic and Wegovy Linked to Surprising Reduction in Violent Behaviour
A Rutgers University study found that GLP-1 receptor agonist drugs like Ozempic and Wegovy may reduce the link between impulsive tendencies and violent acts.
Wegovy Carries Highest Risk of Rare Eye Stroke That Can Cause Sudden Vision Loss
A study based on millions of FDA side-effect reports identified a troubling ocular risk linked to the weight-loss drug.
GLP-1 Weight-Loss Drugs Like Wegovy May Also Target Arthritis Inflammation Say Researchers
A new study found GLP-1 hormones targeted by Ozempic and Wegovy are present in arthritic joints suggesting new treatment potential